Search Results - "Galloway, M P"

Refine Results
  1. 1

    High-dose glycine impairs the prepulse inhibition measure of sensorimotor gating in humans by O’Neill, BV, Croft, RJ, Mann, C, Dang, O, Leung, S, Galloway, MP, Phan, KL, Nathan, PJ

    Published in Journal of psychopharmacology (Oxford) (01-12-2011)
    “…An impaired capacity to filter or ‘gate’ sensory information is a core deficit in cognitive function associated with schizophrenia. These deficits have been…”
    Get full text
    Journal Article
  2. 2

    Serotonin-facilitated dopamine release in vivo: pharmacological characterization by Benloucif, S, Keegan, M J, Galloway, M P

    “…The receptor specificity of serotonin (5-HT) agonist-induced facilitation of dopamine (DA) release was assessed by using in vivo microdialysis. The 5-HT…”
    Get more information
    Journal Article
  3. 3

    Endogenous nitric oxide facilitates striatal dopamine and glutamate efflux in vivo: Role of ionotropic glutamate receptor-dependent mechanisms by West, A.R., Galloway, M.P.

    Published in Neuropharmacology (01-11-1997)
    “…We have investigated the influence of the nitric oxide synthase (NOS) substrate, N G-hydroxy- l-arginine (H-ARG) on dopamine (DA) and glutamate (GLU) efflux in…”
    Get full text
    Journal Article
  4. 4

    MDMA induced dopamine release in vivo : role of endogenous serotonin by KOCH, S, GALLOWAY, M. P

    Published in Journal of Neural Transmission (1997)
    “…Acting as a substrate at the serotonin (5-HT) transporter, (+)-MDMA (3,4-methylenedioxymethamphetamine), is a potent releaser of 5-HT and causes toxicity to…”
    Get full text
    Journal Article
  5. 5

    Region-dependent alterations in glutamate and GABA measured by high-resolution magnetic resonance spectroscopy following acute binge inhalation of toluene in juvenile rats by O'Leary-Moore, S.K, Galloway, M.P, McMechan, A.P, Hannigan, J.H, Bowen, S.E

    Published in Neurotoxicology and teratology (01-07-2007)
    “…Abstract Little is known about the neurochemical effects accompanying the high-concentration inhalant exposures characteristic of binge solvent abuse. In adult…”
    Get full text
    Journal Article
  6. 6

    Nitric oxide and potassium chloride-facilitated striatal dopamine efflux in vivo: role of calcium-dependent release mechanisms by West, A.r, Galloway, M.P

    Published in Neurochemistry international (01-12-1998)
    “…Previous studies investigating the calcium-dependency of nitric oxide-facilitated striatal dopamine efflux have produced conflicting results. In the current…”
    Get full text
    Journal Article
  7. 7

    Dopamine D3-preferring ligands act at synthesis modulating autoreceptors by Aretha, C W, Sinha, A, Galloway, M P

    “…Several compounds exist that demonstrate a binding preference for cloned dopamine D3 receptors vs. D2 receptors, including (+/-)7-OH DPAT, (+)-UH232 and…”
    Get more information
    Journal Article
  8. 8

    Intrastriatal infusion of (+/-)-S-nitroso-N-acetylpenicillamine releases vesicular dopamine via an ionotropic glutamate receptor-mediated mechanism: an in vivo microdialysis study in chloral hydrate-anesthetized rats by West, A R, Galloway, M P

    Published in Journal of neurochemistry (01-05-1996)
    “…The existence of both nitric oxide synthase (NOS) immunoreactive interneurons and amino acid neurotransmitter-mediated nitric oxide (NO) release in the…”
    Get more information
    Journal Article
  9. 9

    Inhibition of glutamate reuptake potentiates endogenous nitric oxide-facilitated dopamine efflux in the rat striatum: an in vivo microdialysis study by West, Anthony R, Galloway, Matthew P

    Published in Neuroscience letters (11-07-1997)
    “…The current study investigated the effects of the nitric oxide synthase (NOS) substrate, N G-hydroxy- l-arginine (H-ARG) and the selective glutamate (GLU)…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation by Hu, XT, Wachtel, SR, Galloway, MP, White, FJ

    Published in The Journal of neuroscience (01-07-1990)
    “…Extracellular single unit recording and microiontophoretic techniques were used to determine the sensitivities and interactions of D1 and D2 dopamine (DA)…”
    Get full text
    Journal Article
  13. 13

    Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis by Benloucif, S, Galloway, M P

    Published in European journal of pharmacology (23-07-1991)
    “…Using microdialysis, changes in extraneuronal levels of dopamine (DA), and the metabolites of DA and serotonin (5-HT), were monitored concurrent with perfusion…”
    Get more information
    Journal Article
  14. 14

    Acute administration of amphetamine: differential regulation of dopamine synthesis in dopamine projection fields by Tyler, C B, Galloway, M P

    “…In order to study the inhibitory mechanisms regulating dopamine (DA) synthesis in vivo, the effect of amphetamine in the presence and absence of selective D1…”
    Get more information
    Journal Article
  15. 15

    Regulation of dopamine synthesis in the medial prefrontal cortex: studies in brain slices by Wolf, M E, Galloway, M P, Roth, R H

    “…The rapid firing rates and small dopamine (DA) pools that characterize mesoprefrontal DA neurons make these cells more vulnerable to release-dependent changes…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Biochemical and fluorodopa positron emission tomographic findings in an asymptomatic carrier of the gene for dopa-responsive dystonia by Takahashi, H, Levine, R A, Galloway, M P, Snow, B J, Calne, D B, Nygaard, T G

    Published in Annals of neurology (01-03-1994)
    “…We report cerebrospinal fluid monoamine metabolite analyses and 6-[18F]fluoro-1-dopa positron emission tomography (FD-PET) from an asymptomatic carrier of the…”
    Get more information
    Journal Article
  18. 18

    Repeated cocaine exposure attenuates the ability of 5-hydroxytryptamine to release striatal dopamine in vivo by Norton, Camille S., Galloway, Matthew P.

    Published in European journal of pharmacology (30-12-1996)
    “…Cocaine was administered repeatedly to rats and striatal microdialysis performed 1, 7, 14, or 21 days after the last cocaine injection. Local perfusion of 10…”
    Get full text
    Journal Article
  19. 19

    Pharmacodynamic modeling of concentration-effect relationships after controlled-release carbidopa/levodopa (Sinemet CR4) in Parkinson's disease by NELSON, M. V, BERCHOU, R. C, LE WITT, P. A, KARETI, D, GALLOWAY, M. P

    Published in Neurology (1990)
    “…Eight parkinsonian patients participated in a pharmacokinetic pharmacodynamic study of sequential doses of controlled-release carbidopa (CD)/levodopa (LD) at…”
    Get full text
    Journal Article
  20. 20

    Desensitization of 5-hydroxytryptamine-facilitated dopamine release in vivo by West, Anthony R., Galloway, Matthew P.

    Published in European journal of pharmacology (18-03-1996)
    “…Desensitization to serotonin (5-hydroxytryptamine, 5-HT)-facilitated dopamine release in vivo develops following either continuous or repeated pulses of 5-HT…”
    Get full text
    Journal Article